Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus helveticus Rosell-52 and Reduced Depression Symptoms

Research synthesisModerate evidenceModerate effect4 studies · 4 beneficial · 0 neutral · 0 harmful

Across 4 studies, all reported beneficial effects of Lactobacillus helveticus Rosell-52 on reducing depressive symptoms, with moderate effect sizes in the highest-quality evidence. A 2025 meta-analysis of 7 RCTs found a significant moderate reduction (SMD, -0.55; 95% CI, -1.04 to -0.06), and a 2025 review of 19 RCTs confirmed significant amelioration of depression status with probiotics. Evidence predominantly targets general adult populations, but study durations and doses were not consistently reported.

  • Studied populations: adults

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 4 studies) — conclusions should be considered preliminary. Doses and study durations were not consistently reported across studies, limiting dose-response and timing conclusions.

Generated Jul 11, 2026
4 of 4 papers
Back to top